Page last updated: 2024-10-24

cefuroxime and Morbid Obesity

cefuroxime has been researched along with Morbid Obesity in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Cefuroxime is a well-established second-generation cephalosporin that is given preoperatively in surgery units at a standard dose of 1."2.74Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. ( Barbour, A; Ben-David, K; Burkhardt, O; Derendorf, H; Rout, WR; Schmidt, S, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbour, A1
Schmidt, S1
Rout, WR1
Ben-David, K1
Burkhardt, O1
Derendorf, H1

Trials

1 trial available for cefuroxime and Morbid Obesity

ArticleYear
Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:3

    Topics: Abdomen; Adipose Tissue; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Chr

2009